Saturday 17 October 2026
Export PMI’s income statement to Excel — free account
Flag Ship Acquisition Corp
PMI Healthcare Medical Devices
Flag Ship Acquisition Corp’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 38.6%, EPS grew 92.8%, free cash flow grew 46.8% and total debt fell 89.8%, each against the same quarter a year earlier.
12.75
2.75
+27.50%
Follow PMI
| Dec '24 | Dec '25 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
Altman Z-Score |
— | (4.36) |
P/S ratio |
9.41 | 12.84 |
Altman Z″-Score (non-manufacturers) |
(35.56) | (14.26) |
P/FCF ratio |
0.00 | 0.00 |
P/Operating CF |
(16.02) | (14.49) |
P/B ratio |
0.00 | 16.74 |
Price to Tangible BV |
0.00 | 23.79 |
EV/Sales |
10.90 | 10.73 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(4.47) | (3.38) |
EV/FCF |
(4.47) | (3.38) |
Quick Ratio |
0.02 | 0.65 |
Current Ratio |
0.28 | 1.11 |
Net Debt/EBITDA |
(0.48) | 1.27 |
Debt/Assets |
43.32% | 4.57% |
Debt/Equity |
(0.22) | 0.27 |
Asset Turnover |
0.00 | 0.29 |
Operating CF/Net income |
0.50 | 0.58 |
Capex/Depreciation |
0.00 | 0.00 |
Interest Coverage |
(4.47) | (2.46) |
| 0.00% | 134.30% | |
| 0.00% | (155.84%) | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
93.80% | (1,219.60%) |
Average Days of Receivables |
51.95 | 55.93 |
Research and Development Expense of Revenue |
76.98% | 61.72% |
Selling, General and Administrative Expense of Revenue |
232.75% | 202.51% |
Intangible Assets out of Total Assets |
0.10 | 0.05 |
Share Based Compensation of Revenue |
20.18% | 15.26% |
Graham Net Nets |
(0.89) | 0.03 |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(64.10%) | (53.56%) |
Free Cash Flow Yield |
(25.89%) | (24.72%) |
Revenue per Share |
27.63 | 6.82 |
Operating CF per Share |
(74.73) | (21.63) |
Capex per Share |
0.00 | 0.00 |
Free Cash Flow per Share |
(74.73) | (21.63) |
Cash per Share |
0.60 | 15.80 |
Shareholders Equity per Share |
(149.38) | 5.23 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(149.38) | 5.23 |
Free Cash Flow |
(11.87) | (15.67) |
Working Capital |
(25.53) | 2.03 |
Net Current Asset Value |
(26.05) | 1.97 |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
12.92 | 27.52 |
Cash ROIC |
64.55% | (96.33%) |
Accounts Receivable Turnover |
0.00 | 7.15 |
Accounts Payable Turnover |
0.00 | 1.40 |
Inventory Turnover |
0.00 | 0.67 |
Average Days of Payables |
429.04 | 147.52 |
Days of Inventory on Hand |
657.78 | 518.20 |
Average Receivables |
— | 0.69 |
Average Payables |
— | 3.69 |
Average Inventory |
— | 7.71 |
Average Assets |
— | 17.33 |
Average Common Equity |
— | (20.11) |
Columns are period end dates